HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Buschor Selected Research

Hypersensitivity (Allergy)

8/2017A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
7/2011Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Buschor Research Topics

Disease

2Hypersensitivity (Allergy)
08/2017 - 07/2011
1Anaphylaxis (Anaphylactic Shock)
08/2017
1Immediate Hypersensitivity
08/2017
1Asthma (Bronchial Asthma)
07/2011

Drug/Important Bio-Agent (IBA)

2Designed Ankyrin Repeat ProteinsIBA
08/2017 - 07/2011
2Proteins (Proteins, Gene)FDA Link
08/2017 - 07/2011
1Carrier Proteins (Binding Protein)IBA
08/2017
1AllergensIBA
08/2017
1Immunoglobulin E (IgE)IBA
08/2017
1Immunoglobulin G (IgG)IBA
08/2017
1Fc Receptors (Fc Receptor)IBA
08/2017
1Pharmaceutical PreparationsIBA
07/2011
1Omalizumab (Xolair)FDA Link
07/2011
1anti-IgE antibodiesIBA
07/2011